Implementing Antimicrobial Stewardship in Various Healthcare Settings

Author:

O. Popoola Olanrewaju

Abstract

Antimicrobial resistance is a global health problem associated with mortality, morbidity, and socioeconomic losses. Given the rapid evolution of microorganisms and the scarcity of novel antimicrobials, it is important to implement strategies that promote appropriate, evidence-based use of antimicrobials to preserve their efficacy. These strategies and interventions are collectively referred to as antimicrobial stewardship (AMS). AMS interventions are focused on ensuring that the right antimicrobials are given at the right dose to the right patient, through the right route and for the right duration of time in order to improve patient outcomes, reduce side effects from inappropriate antimicrobial use and reduce the cost of therapy. AMS interventions include providing patient and public education; educating health professionals; ensuring evidence-based antimicrobial use; strengthening infection prevention and control practices; and prioritizing “one health” focused strategies to mitigate AMR in humans, animals, and the environment. Successful antimicrobial stewardship programs possess seven core elements as recommended by the CDC- leadership commitment, education of health professionals, accountability, drug expertise, action-oriented implementations, regular tracking of adherence to stewardship processes, and reporting. Stewardship interventions are successfully implemented when healthcare workers and stakeholders perceive the benefits of the program to be more than the effort required to implement the change.

Publisher

IntechOpen

Reference45 articles.

1. British Society for Antimicrobial Chemotherapy. Antimicrobial stewardship from principles to practice. 2018. Available from: https://www.bsac.org.uk/antimicrobialstewardshipebook/BSAC-AntimicrobialStewardship-FromPrinciplestoPractice-eBook.pdf [Accessed: April 25, 2023]

2. Murray CJ, Ikuta KS, Sharara F, Swetschinski L, Robles AG, Gray A, et al. Global burden of bacterial antimicrobial resistance in 2019: A systematic analysis. The Lancet. 2022;399(10325):629-655. DOI: 10.1016/S0140-6736(21)02724-0

3. World Bank Group. Drug-Resistant Infections: A Threat to Our Economic Future. Washington, DC: World Bank Group; 2017. Available from: https://www.worldbank.org/en/topic/health/publication/drug-resistant-infections-a-threat-to-our-economic-future [Accessed: May 3, 2023]

4. World Health Organization (WHO). Antimicrobial Stewardship Interventions: A Practical Guide. Copenhagen: WHO Regional Office for Europe; 2021. Available from: https://apps.who.int/iris/handle/10665/340709 [Accessed: May 3, 2023]

5. Ayukekbong JA, Ntemgwa M, Atabe AN. The threat of antimicrobial resistance in developing countries: Causes and control strategies. Antimicrobial Resistance and Infection Control. 2017;6:47. DOI: 10.1186/s13756-017-0208-x

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3